LEADING THE WAY TO BETTER Trademark

Trademark Overview

On Monday, December 23, 2019, a trademark application was filed for LEADING THE WAY TO BETTER with the United States Patent and Trademark Office. The USPTO has given the LEADING THE WAY TO BETTER trademark a serial number of 88737379. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 24, 2023. This trademark is owned by SK Biopharmaceuticals Co., Ltd.. The LEADING THE WAY TO BETTER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment or management of central nervous system disorders, pharmaceutical preparations for the treatment or management of functional gastrointestinal disorders, and pharmaceutical preparations for the treatment or management of cancer
leading the way to better

General Information

Serial Number88737379
Word MarkLEADING THE WAY TO BETTER
Filing DateMonday, December 23, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 24, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment or management of central nervous system disorders, pharmaceutical preparations for the treatment or management of functional gastrointestinal disorders, and pharmaceutical preparations for the treatment or management of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 2, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSK Biopharmaceuticals Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeoul 110-728
KR
Party NameSK Biopharmaceuticals Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeoul 110-728
KR

Trademark Events

Event DateEvent Description
Monday, July 24, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 24, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 3, 2022SOU EXTENSION 5 GRANTED
Friday, September 23, 2022SOU EXTENSION 5 FILED
Monday, October 3, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 23, 2022TEAS EXTENSION RECEIVED
Wednesday, June 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 30, 2022SOU EXTENSION 4 GRANTED
Monday, May 30, 2022SOU EXTENSION 4 FILED
Monday, May 30, 2022TEAS EXTENSION RECEIVED
Tuesday, December 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 3, 2021SOU EXTENSION 3 GRANTED
Friday, December 3, 2021SOU EXTENSION 3 FILED
Friday, December 3, 2021TEAS EXTENSION RECEIVED
Saturday, May 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 20, 2021SOU EXTENSION 2 GRANTED
Thursday, May 20, 2021SOU EXTENSION 2 FILED
Thursday, May 20, 2021TEAS EXTENSION RECEIVED
Friday, December 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 23, 2020SOU EXTENSION 1 GRANTED
Wednesday, December 23, 2020SOU EXTENSION 1 FILED
Wednesday, December 23, 2020TEAS EXTENSION RECEIVED
Tuesday, June 23, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 19, 2020ASSIGNED TO EXAMINER
Thursday, January 2, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 26, 2019NEW APPLICATION ENTERED

Related Keywords

better leading pharmaceutical treatment management preparations disorders gastrointestinal functional cancer nervous central